ClinicalTrials.Veeva

Menu

Comparison on Outcomes of Four IOLs in Patients With Cataracts

T

Tongji University

Status

Completed

Conditions

Visual Outcomes
Cataract
Intraocular Lens

Treatments

Device: TECNIS Symfony ZXR00 intraocular len
Device: ZEISS AT LISA tri 839MP intraocular len
Device: HumanOptics Diff-Aay intraocular lens
Device: TECNIS PCB00 intraocular lens

Study type

Observational

Funder types

Other

Identifiers

NCT06590272
SHSY-LYZX-210

Details and patient eligibility

About

The objective of this study was to compare the objective visual outcomes and subjective fuctional vision of four different intraocular lens (IOL) in patients underwent cataracts surgery. This was a retrospective study. Patients with age-related cataract underwent phacoemulsification combined with IOLs implantation. Patients were divided into 4 groups. Uncorrected distant visual acuity(UDVA), uncorrected intermediate visual acuity (UIVA), uncorrected near visual acuity (UNVA),and the best corrected visual acuity (BCVA) 1 month and 3 months after the surgery were determined. The defocus curve, contrast sensitivity, and customized VF-14-oriented Visual Function Index questionnaire were performed 3 months postoperatively. Kruskal-Wallis test and generalized estimating equation(GEE) were used to analyze and compare the difference between objective visual outcomes and subjective visual quality among different groups.

Full description

The objective of this study was to compare the objective visual outcomes and subjective fuctional vision of four different intraocular lens (IOL) in patients underwent cataracts surgery. This was a retrospective study. Patients with age-related cataract underwent phacoemulsification combined with IOLs implantation. Patients were divided into group A (TECNIS PCB00 IOL), Group B (HumanOptics Diff-Aay IOL), Group C (TECNIS Symfony ZXR00 IOL) and group D (ZEISS AT LISA tri 839MP IOL). Uncorrected distant visual acuity(UDVA), uncorrected intermediate visual acuity (UIVA), uncorrected near visual acuity (UNVA),and the best corrected visual acuity (BCVA) 1 month and 3 months after the surgery were determined. The defocus curve, contrast sensitivity, and customized VF-14-oriented Visual Function Index questionnaire were performed 3 months postoperatively. Kruskal-Wallis test and generalized estimating equation(GEE) were used to analyze and compare the difference between objective visual outcomes and subjective visual quality among different groups.

Enrollment

103 patients

Sex

All

Ages

50 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age-related cataract with myopia≤-6.0D and over 0.0D
  • axial length≤26mm and corneal astigmatism≤1.5D
  • well-cooperation of finishing preoperative examinations
  • completion of all follow-up visits

Exclusion criteria

  • previous eye diseases that affect vision including keratopathy, glaucoma, uveitis, amblyopia, fundus diseases, etc.
  • patients with decreased cognitive ability, unable to cooperate with preoperative examination, or suffering from severe anxiety, depression and mental illness
  • serious complications during operation, including corneal injury, iris injury, expelling choroidal hemorrhage, posterior capsule rupture, etc
  • serious postoperative complications, including displacement of intraocular lens, macular edema, endophthalmitis, etc
  • follow-ups less than 3months

Trial design

103 participants in 4 patient groups

TECNIS PCB00 IOL (A)
Description:
The patients in this groups underwent cataract surgery with TECNIS PCB00 IOL
Treatment:
Device: TECNIS PCB00 intraocular lens
HumanOptics Diff-Aay IOL (B)
Description:
The patients in this groups underwent cataract surgery with HumanOptics Diff-Aay IOL
Treatment:
Device: HumanOptics Diff-Aay intraocular lens
TECNIS Symfony ZXR00 IOL (C)
Description:
The patients in this groups underwent cataract surgery with TECNIS Symfony ZXR00 IOL
Treatment:
Device: TECNIS Symfony ZXR00 intraocular len
ZEISS AT LISA tri 839MP IOL (D)
Description:
The patients in this groups underwent cataract surgery with ZEISS AT LISA tri 839MP IOL
Treatment:
Device: ZEISS AT LISA tri 839MP intraocular len

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems